HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Correction (v62,p1892) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John R. Benfield Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Edelman, M. J. Articles by Benfield, J. R. Search for Related Content PubMed PubMed Citation Articles by Edelman, M. J. Articles by Benfield, J. R.

Ann Thorac Surg 1996;61:1564-1572
© 1996 The Society of Thoracic Surgeons

---

Current Reviews

Multimodality Therapy in Stage III Non-Small Cell Lung Cancer

Divisions of Hematology/Oncology and Cardiothoracic Surgery, University of California, Davis, and VA Northern California Health Care System, Martinez; and Department of Radiation Oncology, University of California, San Francisco, California

Background. Non-small cell lung cancer commonly presents as locally advanced disease. This category of tumors is heterogeneous. Although some patients clearly benefit from operative management alone, the vast majority (more than 90%) will succumb to their disease within 5 years. In the past decade a large clinical research effort has been undertaken in an attempt to improve on this outcome using a combination of chemotherapy, radiotherapy, and operation.

Methods. The English-language literature was reviewed using the headings for lung neoplasms and text words combined modality therapy and multimodality therapy. In addition, the bibliographies of relevant articles were reviewed. Emphasis was placed on prospective randomized trials and large phase II studies. We review the rationale, design, and outcome of these trials, including both operative and nonoperative approaches.

Results. Several prospective, randomized trials now demonstrate an advantage to combined modality management over radiotherapy or operation alone when a cisplatin-based chemotherapy regimen is incorporated into the treatment plan. This advantage was seen using both operative and nonoperative approaches.

Conclusions. Combined modality therapy offers an improved outcome for patients with stage III non-small cell lung cancer. Whether both operation and radiotherapy are needed for local control, the best sequence of treatment and the optimal chemotherapy regimen remain to be defined.

This article has been cited by other articles:

				M. J. Edelman, M. Suntharalingam, W. Burrows, K. F. Kwong, N. Mitra, Z. Gamliel, M. Riley, L. B. Cooper, N. L. Kennedy, S. Buskirk, et al. Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer Ann. Thorac. Surg., September 1, 2008; 86(3): 903 - 910. [Abstract] [Full Text] [PDF]

				J. R. Sonett, M. Suntharalingam, M. J. Edelman, A. B. Patel, Z. Gamliel, A. Doyle, P. Hausner, and M. Krasna Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non-Small-Cell Lung Cancer Ann. Thorac. Surg., October 1, 2004; 78(4): 1200 - 1205. [Abstract] [Full Text] [PDF]

				D. R. Gandara, K. Chansky, K. S. Albain, B. R. Leigh, L. E. Gaspar, P. N. Lara Jr, H. Burris, P. Gumerlock, J. P. Kuebler, J. D. Bearden III, et al. Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 J. Clin. Oncol., May 15, 2003; 21(10): 2004 - 2010. [Abstract] [Full Text] [PDF]

				C. Doddoli, P. Thomas, X. Thirion, Y. Seree, R. Giudicelli, and P. Fuentes Postoperative complications in relation with induction therapy for lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 385 - 390. [Abstract] [Full Text] [PDF]

				M. Pauwels, P. Van Schil, W. De Backer, F. Van den Brande, and E. Eyskens Repeat mediastinoscopy in the staging of lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 14(3): 271 - 273. [Abstract] [Full Text] [PDF]

				L. H. Einhorn Neoadjuvant and Adjuvant Trials in Non-Small Cell Lung Cancer Ann. Thorac. Surg., January 1, 1998; 65(1): 208 - 211. [Abstract] [Full Text] [PDF]

				P. E. Y. Van Schil Mediastinal lymph node metastasis in patients with clinical stage I lung cancer J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 511 - 511. [Full Text]